Back Menu
id опорной категории = 2
id текущей категории = 1
id родительской категории = 1

Press-releases

HSCI Announces 1H 2020 Consolidated Results under IFRS 07.09.2020

Moscow – 7 September, 2020. PJSC “HSCI” – The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, today announced its reviewed consolidated interim results for the first half of 2020 in accordance with the International…

Read More
HSCI Announces 1H2018Consolidated Results under IFRS 29.08.2018

Moscow – 29 August, 2018. PJSC “HSCI”–The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, today announced its reviewedconsolidated interim results for the first half of 2017in accordance with the International Financial Reporting Standards (IFRS)….

Read More
HSCI Announces 2017 Consolidated Results under IFRS 03.05.2018

HSCI Announces 2017 Consolidated Results under IFRS Moscow – 03 may, 2018.   PJSC “HSCI” – The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, today announced its audited consolidated results for 2017 in accordance with…

Read More
HSCI Announces h1 2017 Consolidated Results Under IFRS 29.08.2017

Moscow – 29 August, 2017.   PJSC “HSCI” – The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, today announced its reviewed consolidated interim results for the first  half of 2017 in accordance with the International…

Read More
Change in Shareholding Structure of HSCI 14.01.2014

Moscow – 14 January 2014 OJSC HSCI – The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies specializing in cell-based, gene and post-genome technologies, today announces a change in the company’s shareholding structure. Artur Isaev,…

Read More